CLINICAL_TRIALS
trial_result
· 2013-08-21
Clinical Trial Update: Safety and Efficacy Study of Autologous Fibroblasts in the Treatment of Severe Facial Acne Scarring [Phase 2, Phase 3]
Summary
Phase 2/3 study evaluating autologous fibroblasts for severe facial acne scarring completed, with safety and efficacy results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Castle Creek Biosciences, LLC. | Conditions: Acne Scarring of the Face | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-08-21